Unichem Laboratories Profit & Loss Annual

BSE: 506690 | NSE: UNICHEMLAB | ISIN: INE351A01035 | Sector: Major Drugs

533.75 +4.65 (0.88%)Updated : 09 Oct 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	2,214.47	1,970.67	1,882.22	1,535.57
Other Net	0.02	-1.18	-1.42	-0.87
Diluted Weighted Average Shares	7.05	7.06	7.04	7.04
Gain( Loss)on Saleof Assets	275.52	0.95	4.85	1.28
Depreciation/ Amortization	125.12	124.56	123.16	113.44
Operating Income	-12.62	140.30	-97.11	-192.54
Net Income	252.84	137.52	-93.76	-202.23
Income Availableto Com Excl Extra Ord	252.84	137.52	-93.76	-202.23
Net Income Before Taxes	292.38	154.59	-84.96	-176.36
Net Income After Taxes	252.84	137.52	-93.76	-202.23
Income Availableto Com Incl Extra Ord	252.84	137.52	-93.76	-202.23
Costof Revenue Total	1,126.81	971.83	843.84	673.17
Gross Profit	1,075.04	1,139.14	941.27	669.85
Interest Inc( Exp) Net- Non- Op Total	29.46	14.52	8.72	15.77
Unusual Expense( Income)	71.67	0.00	60.83	36.96
Diluted Net Income	252.84	137.52	-93.76	-202.23
Provisionfor Income Taxes	39.54	17.07	8.80	25.86
period Type	-	-	-	-
Net Income Before Extra Items	252.84	137.52	-93.76	-202.23
Total Revenue	2,201.85	2,110.97	1,785.11	1,343.02
period Length	12.00	12.00	12.00	12.00
Revenue	2,201.85	2,110.97	1,785.11	1,343.02
Selling/ General/ Admin Expenses Total	890.87	874.28	854.39	711.99
Diluted Normalized EPS	10.85	19.35	-8.15	-25.43
Diluted EPS Excluding Extra Ord Items	35.85	19.47	-13.32	-28.72
DPS- Common Stock Primary Issue	-	-	-	0.00